Latest AI and machine learning research in other cancers for healthcare professionals.
Emerging evidence links reactive oxygen species modulator 1 (ROMO1), a key mitochondrial ROS regulator, to rheumatoid arthritis (RA) pathogenesis. However, its exact mechanism remains elusive given the conflicting evidence about its specific function. We used a four-level integrative framework combining multi-omics data and literature‑supported mechanistic inference. At the genetic level, Mendelia...
BACKGROUND: Colorectal cancer (CRC) ranks as the third highest incidence among malignancies for human and the second most common cause of cancer-related mortality in the United States. Accumulating evidence has established microRNAs (miRNAs) as critical regulators of cancer development and therapeutic response. Understanding miRNA-mRNA interactions is critical for elucidating the molecular mechani...
Small interfering RNA (siRNA) therapeutics have emerged as a transformative approach for sequence-specific gene silencing, offering the potential to t...
RATIONALE AND OBJECTIVES: To map artificial intelligence (AI) and radiomics applications in computed tomography (CT), magnetic resonance imaging (MRI)...
PURPOSE: To develop and externally validate an ultrasound-based habitat subregional radiomics model for preoperative prediction of invasive breast can...
The relationship between diabetes mellitus and prostate cancer (PC) represents one of the most intriguing paradoxes in cancer epidemiology, with diabe...
Pancreatic ductal adenocarcinoma (PDAC) remains a formidable malignancy characterized by late diagnosis, high recurrence rates, and pronounced chemore...
This study aimed to develop and validate machine learning (ML) models integrating clinical parameters and the 2PI system (Pathology and Prognosis-Info...
Deep learning (DL) methods are increasingly applied to digitized hematoxylin and eosin (H&E) slides in breast cancer to assist in staging and prognosi...
BACKGROUND AND AIMS: Percutaneous transhepatic biliary drainage (PTBD) is a standard palliative intervention for malignant obstructive jaundice, yet 6...
PURPOSE: Preoperative differentiation between benign and malignant parotid tumors (PTs) remains challenging despite clinical examination, cross-sectio...
BACKGROUND: Human papilloma virus (HPV)-related head and neck squamous cell carcinoma (HNSCC) incidence is rising. Despite the prognostic and therapeu...
BACKGROUND: High-grade serous ovarian carcinoma (HGSOC) features extensive intratumoral heterogeneity, frequent chemoresistance and poor prognosis. Tu...
OBJECTIVE: This study aimed to develop a deep learning model (MST-Net) for the segmentation-free automated and precise differentiation between T2 and ...
Chronic kidney disease staging from longitudinal clinical records is challenging because routinely recorded GP stage labels are scarce, whereas rule-b...
Breast cancer exhibits significant spatiotemporal heterogeneity. Traditional radiomics approaches usually rely on low-temporal-resolution imaging and ...
Multiple myeloma (MM) is a malignant blood cancer marked by severe bone destruction and immune microenvironment disruption. Yet relapse and drug resis...
Pancreatic adenocarcinoma (PAAD) remains one of the most lethal cancers, largely due to the lack of reliable diagnostic biomarkers. Through integrativ...
RATIONALE AND OBJECTIVES: To develop and validate a brain imaging-based multimodal radiomics model for noninvasive prediction of pathological subtypes...
To explore the role of N4-acetylcytidine (ac4C)-related genes (acRGs) in colon adenocarcinoma (COAD) and identify reliable prognostic biomarkers and p...